Cellulose- and lignin-based smart hydrogels for barrier-adaptive delivery of fragile biotherapeutics: Molecular design, activity preservation, and translational considerations.
A translational evidence framework is proposed that links raw-material identity and network transformation to payload integrity, biological activity, safety, manufacturability, sterilization, storage stability, quality control, and regulatory readiness for fragile biotherapeutics.